Healthcare Press Releases

LocalSearchForDentists.com Ranks No. 357 on the 2014 Inc. 500

Inc. magazine released the 2014 Inc.500 list, placing LocalSearchForDentists.com #357 on the exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at America’s independent entrepreneurs, the most important segment of today’s economy. Companies such as Microsoft, Zappos, Intuit, Jamba Juice, Zipcar, Clif Bar, Vizio, Oracle, and many other well-known names gained crucial early exposure as members of the Inc. 500.

Dr. Gaudio Uses New Technology for Early Oral Cancer Detection

The Oral Cancer Foundation (OCF), states that close to 43,250 Americans will be diagnosed with oral or pharyngeal (throat) cancer this year. It will cause over 8,000 deaths, killing roughly one person per hour, 24 hours per day. Of those 42,000 diagnosed individuals, only slightly more than half will be alive in five years. This is a number that has not significantly improved in decades. With statistics like these, Dr. Gaudio calls for action, “I want all of my patients to come in and have the OralCDx test done as soon as possible. The earlier we catch the bad cells, the better chance we have of saving lives.”

Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014: New Research Report Available at Fast Market Research

LogoGlobalData's clinical trial report, "Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Transitional Cell Cancer (Urothelial Cell Cancer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Transitional Cell Cancer (Urothelial Cell Cancer). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 - New Market Study Published

LogoGlobalData's clinical trial report, "Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Market Report, "Ocular Melanoma Global Clinical Trials Review, H1, 2014", Published

LogoGlobalData's clinical trial report, "Ocular Melanoma Global Clinical Trials Review, H1, 2014" provides data on the Ocular Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Report Published: "Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014"

LogoGlobalData's clinical trial report, "Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Pleural Mesothelioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Pleural Mesothelioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Pleural Mesothelioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

New Market Study Published: Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014

LogoGlobalData's clinical trial report, "Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014" provides data on the Opioid-Induced Constipation (OIC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid-Induced Constipation (OIC). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Opioid-Induced Constipation (OIC). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Malignant Fibrous Histiocytoma of Bone Global Clinical Trials Review, H1, 2014 - New Market Research Report

LogoGlobalData's clinical trial report, "Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014" provides data on the Malignant Fibrous Histiocytoma Of Bone clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Fibrous Histiocytoma Of Bone. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Fibrous Histiocytoma Of Bone. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Recent Study: Oral Mucositis Global Clinical Trials Review, H1, 2014

LogoGlobalData's clinical trial report, "Oral Mucositis Global Clinical Trials Review, H1, 2014" provides data on the Oral Mucositis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oral Mucositis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oral Mucositis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Recent Study: Refractory Leukemia Global Clinical Trials Review, H1, 2014

LogoGlobalData's clinical trial report, "Refractory Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Refractory Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia - New Market Research Report

LogoGlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Dr. Dmitri Alden, Renowned NYC Surgical Oncologist, Nominated for Top Liver & Pancreatic Cancer Surgeon

Dmitri Alden, MD, http://liversurgeryny.com, a NYC liver, pancreatic & bile duct cancer surgeon, has been nominated by Castle Connolly Medical Ltd., “America's Trusted Source for Identifying Top Doctors”, as one of “America’s Top Doctors” for his achievements in liver & pancreatic cancer surgery. Dr. Alden performs more than 200+ liver cancer, pancreatic cancer, and bile duct surgeries a year and has performed over 3500 surgeries in the past 11 years.

Austin Dentist Dr. Heather Fagin Joins Well Respected Dental Team at Lakeway Smiles TX

Austin dental patients have something to smile about, with Dr. Heather Fagin joining the team at the Lakeway Smiles dental offices. Dr. Fagin's work in dentistry has earned her honors and awards in both dental and medical communities and journals, along with the respect and affection of patients she has cared for in her 14 year career, over a decade of which has been spent in the Austin area.

New York Female Plastic Surgeon Launches a New, Re-Designed Adaptive Responsive Website

Dr. Nina S. Naidu, a renowned and respected plastic and reconstructive plastic surgeon in New York has launched a new website devoted to patient knowledge and well-being. The new website is meant to serve as a source of reliable information to which patients can turn to when they have questions about new procedures and/or techniques.

MXI Corp Team Leader Proudly Endorses Global-Partners for Providing Safe-Working-Conditions for XO-Love-Bites in Japan

LogoMXI Corp team leader, Adam Green, has proudly endorses global partners for providing safe working conditions for their Xocai XO-Love-Bites in Japan.

Elliptical Cardio Publishes New Editorial on the Benefits of Elliptical Workouts

Cardio is the most important form of exercise, as it increases the body’s ability to operate for longer periods of time under higher levels of strain. There are many forms of cardio exercise, but most people use running, swimming or cycling to do steady state exercise that maintains an elevated heart rate. Science has advanced beyond this however, and Elliptical Cardio offers interesting insight into new developments in their newly published editorial, explaining not only how to get the best results, but that an elliptical can improve performance over these traditional approaches.

The Venus Factor Review by TheHealthDiaries Examines the Real Truth About the Women's Weight Loss Program

The Venus Factor System is a new product developed for helping women worldwide lose weight and gain a bikini body. The Venus Factor System Review aims helping customers to decide whether investing or not their saving to get The Venus Factor System new revolutionary weight loss program designed for women. Customers who are looking to purchase this new system called The Venus Factor System are on this page because they are looking for more information and description that the product has. This is why Daily Gossip Magazine reviewed The Venus Factor System guide for helping people to find more information, description, features and customer reviews.

Female Libido Enhancer Revealed on a Newly Launched Site

Women all over the world are experiencing a loss of their sexual libido in one point of their life or another. The reasons as to why this is happening vary a great deal. Normally this occurrence is associated with physical causes that may include sex-related problems, alcohol and drugs among others. Also, personal or professional level anxiety has also been highlighted as one of the causes of a low or nonexistent sexual drive.

Revitol Scar Cream Reduces the Appearance of Unsightly Scars: Available in Philippines

Revitol scar cream has made its way in the Philippines as well. The company announced the introduction of the product in the market of Philippines last week. The cream getting worldwide attention and positive reviews for treating skin problems.

Garcinia Cambogia Extract Is Now Known Around the World for Its Fat Burning and Slimming Benefits

Garcinia Cambogia Extract is now known around the world for its fat burning and slimming benefits, scientific research is further validating the fact that Garcinia Cambogia is in fact one of the most effective weight loss supplement out there. The miracle extract is derived from the Garcinia Cambogia fruit which is a small pumpkin shaped fruit that grows in Southeast Asia and is used commonly used in cooking for its tangy flavor, the extract used in Garcinia Cambogia pills comes from the rind of the fruit which contains high levels of Hydroxycitric Acid (HCA). It is this Hydroxycitric Acid (HCA) which is the primary active compound that promotes weight loss and fat burn.

Healthy Style Mart Supplement Superstore Offers Affordable Health Products and Vitamins

Healthy Style Mart, the popular online supplement superstore, is offering more diverse products for customers. Aside from the expanded product category though, the company assured clients that the money back guarantee and secure shopping features are still there.

Melanie Addington's The Ultimate Herpes Protocol - Does the Protocol Really Provide Guard Against Herpes?

The Ultimate Herpes Protocol, is a program that has been designed specifically to help the victims of the herpes virus to achieve a life-time riddance from the disease in a way that was never thought possible before. The most surprising element here is that the program is based on 100% natural remedies instead of any medicinal drugs or chemical formulas. This protocol is the work of Melanie Addington in collaboration with her father whose medicinal capabilities are very highly regarded in Britain.

MXI Corp Ripped-and-Rich Update: Adam Green Announces New Weight Loss System & Lifestyle Program for Healthy Chocolate Distributors

LogoAdam Paul Green, a Xocai Ambassador is pleased to announces the all new weight loss system and lifestyle program for Xocai Healthy Chocolate Distributors and for mountain biking athletes.

The Venus Factor Review: Will It Really Help Users Lose That Extra Fat? Discover the Secrets Behind This Weight Loss Product

The Venus Factor, is a step-by-step guide that has been designed specifically to help women get rid of their excess weight problem as if it never even existed in the first place. It is a nutrition plan prepared specially for women, based on a period of 12 weeks. The plan is designed such that spectacular results can be seen by the end of the 12th week without using any chemical formulas, supplements, giving up on tasty food or even taking up unnecessarily long, strenuous exercises at the gym. It is the outcome of John Barban’s years of study and research of the subject matter. John holds a Master’s degree in Human Biology and Nutrition.

CEL-SCI Reports April 2014 Is Another Record Month for Patient Enrollment in Its Phase III Head and Neck Cancer Trial

CEL-SCI Corporation today announced that during the month of April 2014 the Company enrolled 21 patients with advanced primary, not yet treated, head and neck cancer into its global Phase III head and neck cancer trial for its investigational immunotherapy Multikine (Leukocyte Interleukin, Injection). This marks a substantial increase over the previous monthly record of 14 patients in March 2014.

Non-Invasive Thread Vein Treatment Now Available from London Clinic

City Hair Removal is a laser hair removal clinic based in Fenchurch Street, London. The well established clinic employs highly experienced and trained staff and has invested heavily in state of the art equipment. City Hair Removal is pleased to treat more than 50 clients a day, 6 days a week.

Lifecell Cream Effective in Taking Care of Many Skin Problems: Report

LifeCell Cream today released a new report based on the clinical studies outsourced to a recognized lab. The report calls the product as effective when it comes to getting health skin. With the release of report, LifeCell announced its entry in New Zealand as well. The report also confirms that the cream provides protection from UV rays and is helpful in removing the signs of aging in a short time of just 17 seconds. The product has been approved by a number of skin experts and dermatologists from across the globe. One of the most renowned dermatologists, Janet Allenby also researched the ingredients of this product.